Informed patients are empowered patients. Which is why helping people with cancer understand their disease, as well as how available treatment options might work for them, is a critical focus of our patient advocacy efforts.
Through conversations with patient advocates, patients and patient advocacy organizations, Daiichi Sankyo identified the need for a resource describing the science behind antibody drug conjugates, a class of anti-cancer therapies designed to target and kill tumor cells while reducing toxicity to healthy cells. With input from patient advocacy partners, we created Understanding Antibody Drug Conjugates (ADCs), a three-minute video that uses visual metaphors and animation to explain this therapy option used for certain cancers.
Watch the educational video our advocacy partners are sharing with patients and their caregivers who are looking for more information about new treatment options:
The Understanding Antibody Drug Conjugates video is just one example of how Daiichi Sankyo is translating science for people with cancer to support patient education and decision making.
You and your doctor are a team in your care. This video is intended for U.S. consumers and for informational purposes only and is not intended to be a substitute for medical advice. Talk with your doctor to learn more about your disease and treatment.
Suggestions
Tara Rowek, Senior Study Associate, explains how collaboration, attention to detail and patient-centered clinical research help maintain quality, strengthen clinical trials and advance potential new treatment options for patients.
Daiichi Sankyo CARE Teams go above and beyond educating healthcare providers about our medicines and providing patient support. Discover how we CARE...
While our lungs support our very existence, we often don’t recognize that something isn’t quite right with our lung health. Get answers to questions about lung cancer and listen to empowered patients...